Mode
Text Size
Log in / Sign up

Twice-weekly telemedicine home ultrasound reduces anxiety in pregnant patients with prior late pregnancy loss.

Twice-weekly telemedicine home ultrasound reduces anxiety in pregnant patients with prior late pregn…
Photo by JOVS Beauty / Unsplash
Key Takeaway
Consider twice-weekly telemedicine home ultrasound for reducing anxiety in pregnant patients with prior late pregnancy loss.

This quasi-randomized trial involved 50 participants, with 25 per group, who had a history of late pregnancy loss. The intervention consisted of twice-weekly telemedicine home ultrasound sessions conducted in a home setting, compared to standard high-risk care. Follow-up lasted 4.6 months. Regression analyses confirmed independent associations between home ultrasound use, reduced anxiety, and improved attachment.

The primary outcome measured STAI-S scores at the final visit, with secondary outcomes including maternal anxiety at mid-pregnancy and final visit, antenatal attachment at the final visit, attachment scores during follow-up, and emergency department visits. At mid-pregnancy, the intervention group had significantly lower STAI-S scores (46.7 ± 9.3 vs. 52.0 ± 9.0; p = 0.023). At the final visit, STAI-S scores remained significantly lower in the intervention group (43.6 ± 11.8 vs. 51.5 ± 11.5; p = 0.004).

Regarding attachment, MAAS-2 scores at the final visit were higher in the intervention group (79.5 ± 6.2 vs. 75.0 ± 6.9; p = 0.022). Attachment scores during follow-up increased significantly in the intervention group (4.8 ± 7.3 vs. -0.36 ± 8.0; p = 0.023). Additionally, emergency department visits were fewer in the intervention group (3.1 ± 1.5 vs. 4.9 ± 3.3; p = 0.024). Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported. The study supports integrating this approach into standard prenatal management for this vulnerable population, though the quasi-randomized design limits causal inference.

Study Details

Study typeRct
Sample sizen = 50
EvidenceLevel 2
Follow-up4.6 mo
PublishedApr 2026
View Original Abstract ↓
PURPOSE: To evaluate the effect of incorporating twice-weekly telemedicine home ultrasound sessions on maternal anxiety and antenatal attachment in pregnant patients with a history of late pregnancy loss. METHODS: In this quasi-randomized trial, pregnant patients with a previous pregnancy loss beyond 20 weeks of gestation were randomized per day of enrollment to standard high-risk care (control) or additional twice-weekly home ultrasound sessions (intervention). Maternal anxiety and antenatal attachment were assessed at baseline, mid-pregnancy, and final prenatal visit using the State-Trait Anxiety Inventory Scale (STAI-S) and the Maternal Antenatal Attachment Scale (MAAS-2). The primary outcome was the STAI-S score at the final visit. A total of 50 participants (25 per group) were required to detect a 20% difference in the primary outcome. RESULTS: Demographics were comparable between groups. The intervention group demonstrated significantly lower STAI-S scores at mid-pregnancy (46.7 ± 9.3 vs. 52.0 ± 9.0; p = 0.023) and at the final visit (43.6 ± 11.8 vs. 51.5 ± 11.5; p = 0.004), and higher MAAS-2 scores at the final visit (79.5 ± 6.2 vs. 75.0 ± 6.9; p = 0.022). Attachment scores increased significantly during follow-up (4.8 ± 7.3 vs. - 0.36 ± 8.0; p = 0.023). Emergency department visits were fewer in the intervention group (3.1 ± 1.5 vs. 4.9 ± 3.3; p = 0.024). Regression analyses confirmed independent associations between home ultrasound use, reduced anxiety, and improved attachment. CONCLUSION: Telemedicine home ultrasound significantly reduced maternal anxiety and improved antenatal attachment in patients with prior late pregnancy loss. This reassurance strategy may also decrease unscheduled emergency visits, supporting its integration into standard prenatal management in this vulnerable population.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.